Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 55 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Nemolizumab for treating atopic dermatitis and prurigo nodularis	Nemolizumab	Atopic dermatitis , Prurigo nodularis (PN)	Dermatology	2022	View \| Download
Nintedanib for Systemic Sclerosis Associated Interstitial Lung Disease	Nintedanib (Vargatef; Ofev; nintedanib esilate)	Interstitial lung disease (ILD)	Dermatology , Respiratory System	2018	View \| Download
Nintedanib for treating interstitial lung disease in children aged 6 to 17 years old	Nintedanib (Vargatef; Ofev; nintedanib esilate)	Interstitial lung disease (ILD)	Dermatology , Respiratory System	2022	View \| Download
Oleogel-S10 for Inherited Epidermolysis Bullosa	Oleogel-S10 (Episalvan)	Inherited epidermolysis bullosa (EB)	Dermatology , Genetic Disorders	2018	View \| Download
Omalizumab biosimilar for treating chronic spontaneous urticaria	Omalizumab biosimilar	Chronic spontaneous urticaria (CSU)	Dermatology	2023	View \| Download
Remibrutinib for treating chronic spontaneous urticaria inadequately controlled by H1-antihistamines	Remibrutini (LOU064)	Chronic spontaneous urticaria (CSU)	Dermatology	2023	View \| Download
Risankizumab (by subcutaneous injection) for Active Psoriatic Arthritis After Inadequate Control or Intolerance to Conventional Drugs	Risankizumab (BI 655066; Skyrizi; ABBV 066)	Psoriatic arthritis	Dermatology , Rheumatology	2017	View \| Download
Risankizumab (by Subcutaneous Injection) for Moderate to Severe Chronic Plaque Psoriasis	Risankizumab (BI 655066; Skyrizi; ABBV 066)	Plaque psoriasis	Dermatology	2017	View \| Download
Ritlecitinib for alopecia areata	Ritlecitinib (PF-06651600)	Alopecia areata	Dermatology , Immunology	2021	View \| Download
Rituximab for Pemphigus Vulgaris	Rituximab (MabThera; Rituxan; RG 105)	Pemphigus vulgaris	Dermatology , Immunology	2018	View \| Download